echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hisun Pharmaceutical's micafungin sodium for injection passed the consistency evaluation of generic drugs

    Hisun Pharmaceutical's micafungin sodium for injection passed the consistency evaluation of generic drugs

    • Last Update: 2021-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the 24th, Hisun Pharmaceuticals announced that it had received the "Drug Supplementary Application Approval Notice" for micafungin sodium for injection approved and issued by the State Food and Drug Administration.


    Micafungin sodium is mainly used for the following infections caused by Aspergillus and Candida: fungemia, respiratory fungal disease, gastrointestinal fungal disease


    According to statistics, the global sales of Micafungin Sodium for Injection in 2020 will be approximately US$339,152,600, of which China’s sales will be approximately US$34,427,300; the global sales from January to March 2021 will be approximately US$82.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.